Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 355

1.

Olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC): Alliance A221301, a randomized, double-blind, placebo-controlled trial.

Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich LL, Lafky JM, Loprinzi CL.

J Clin Oncol. 2015 Oct 10;33(29_suppl):176. doi: 10.1200/jco.2015.33.29_suppl.176.

PMID:
28147995
2.

Scrambler Therapy for the Treatment of Chronic Post-Mastectomy Pain (cPMP).

Smith T, Cheville AL, Loprinzi CL, Longo-Schoberlein D.

Cureus. 2017 Jun 21;9(6):e1378. doi: 10.7759/cureus.1378.

3.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS.

Support Care Cancer. 2017 Jun 20. doi: 10.1007/s00520-017-3780-y. [Epub ahead of print]

PMID:
28634656
4.

A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.

Pachman DR, Dockter T, Zekan PJ, Fruth B, Ruddy KJ, Ta LE, Lafky JM, Dentchev T, Le-Lindqwister NA, Sikov WM, Staff N, Beutler AS, Loprinzi CL.

Support Care Cancer. 2017 May 27. doi: 10.1007/s00520-017-3760-2. [Epub ahead of print]

PMID:
28551844
5.

Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.

Himelstein AL, Loprinzi CL, Shapiro CL.

JAMA. 2017 Apr 11;317(14):1478. doi: 10.1001/jama.2017.2566. No abstract available.

PMID:
28399247
6.

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB.

Breast Cancer Res Treat. 2017 Jul;164(1):69-77. doi: 10.1007/s10549-017-4230-8. Epub 2017 Apr 3.

PMID:
28374323
7.

Chemotherapy-induced neuropathy: Central resolution of a peripherally perceived problem?

Cathcart-Rake EJ, Hilliker DR, Loprinzi CL.

Cancer. 2017 Jun 1;123(11):1898-1900. doi: 10.1002/cncr.30650. Epub 2017 Mar 3. No abstract available.

PMID:
28257145
8.

Statistical controversies in clinical research: Value of adverse events relatedness to study treatment: analyses of data from randomized double-blind placebo-controlled clinical trials.

Le-Rademacher J, Hillman SL, Meyers J, Loprinzi CL, Limburg PJ, Mandrekar SJ.

Ann Oncol. 2017 Jun 1;28(6):1183-1190. doi: 10.1093/annonc/mdx043.

PMID:
28184420
9.

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL.

JAMA. 2017 Jan 3;317(1):48-58. doi: 10.1001/jama.2016.19425.

10.

Management of hot flashes in women with breast cancer receiving ovarian function suppression.

Leon-Ferre RA, Majithia N, Loprinzi CL.

Cancer Treat Rev. 2017 Jan;52:82-90. doi: 10.1016/j.ctrv.2016.11.012. Epub 2016 Dec 5. Review.

PMID:
27960127
11.

New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.

Majithia N, Loprinzi CL, Smith TJ.

Oncology (Williston Park). 2016 Nov 15;30(11):1020-9. Review.

12.

Fit for Chemo: Nerves May Thank You.

Leon-Ferre R, Ruddy KJ, Staff NP, Loprinzi CL.

J Natl Cancer Inst. 2016 Oct 28;109(2). pii: djw208. Print 2017 Feb. No abstract available.

PMID:
27794125
13.

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

Pachman DR, Qin R, Seisler D, Smith EM, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL.

Support Care Cancer. 2016 Dec;24(12):5059-5068. Epub 2016 Aug 18.

14.

Management of Hormone Deprivation Symptoms After Cancer.

Faubion SS, Loprinzi CL, Ruddy KJ.

Mayo Clin Proc. 2016 Aug;91(8):1133-46. doi: 10.1016/j.mayocp.2016.04.009. Review.

PMID:
27492917
15.

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, Biggs D, Lafky JM, Loprinzi CL.

N Engl J Med. 2016 Jul 14;375(2):134-42. doi: 10.1056/NEJMoa1515725.

16.

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Miller RC, Petereit DG, Sloan JA, Liu H, Martenson JA, Bearden JD 3rd, Sapiente R, Seeger GR, Mowat RB, Liem B, Iott MJ, Loprinzi CL; Alliance for Clinical Trials in Oncology.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1168-74. doi: 10.1016/j.ijrobp.2016.01.063. Epub 2016 Apr 23.

17.

Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.

Monfort SM, Pan X, Patrick R, Singaravelu J, Loprinzi CL, Lustberg MB, Chaudhari AMW.

Gait Posture. 2016 Jul;48:237-242. doi: 10.1016/j.gaitpost.2016.06.011. Epub 2016 Jun 14.

18.

Olanzapine versus fosaprepitant for the prevention of concurrent chemotherapy radiotherapy-induced nausea and vomiting.

Navari RM, Nagy CK, Le-Rademacher J, Loprinzi CL.

J Community Support Oncol. 2016 Apr;14(4):141-7. doi: 10.12788/jcso.0245.

PMID:
27152512
19.

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254.

Thanarajasingam G, Atherton PJ, Novotny PJ, Loprinzi CL, Sloan JA, Grothey A.

Lancet Oncol. 2016 May;17(5):663-70. doi: 10.1016/S1470-2045(16)00038-3. Epub 2016 Apr 12.

20.

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

Sio TT, Atherton PJ, Birckhead BJ, Schwartz DJ, Sloan JA, Seisler DK, Martenson JA, Loprinzi CL, Griffin PC, Morton RF, Anders JC, Stoffel TJ, Haselow RE, Mowat RB, Wittich MA, Bearden JD 3rd, Miller RC.

Support Care Cancer. 2016 Sep;24(9):3847-55. doi: 10.1007/s00520-016-3213-3. Epub 2016 Apr 14.

PMID:
27075674

Supplemental Content

Loading ...
Support Center